CCO Expert Recap

Update on Investigational Agents in HCV: 2007

Source: CCO Independent Conference Coverage of the 2007 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on Investigational Agents in HCV: 2007

Faculty:

Ira M. Jacobson, MD

CME CREDIT INFORMATION

Release Date: 01/07/08

Expiration Date: 01/06/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss emerging efficacy and safety data on small-molecule specifically targeted anti-HCV agents
Describe the current understanding of resistance mutations with investigational agents
Summarize data on novel immunomodulatory agents with anti-HCV activity

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.